{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T09:25:54Z","timestamp":1777022754563,"version":"3.51.4"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1097\/md.0000000000005924","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:05:45Z","timestamp":1495573545000},"page":"e5924","source":"Crossref","is-referenced-by-count":14,"title":["Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients"],"prefix":"10.1097","volume":"96","author":[{"given":"Tariq","family":"Shafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Luly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen J.","family":"Bandeen-Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy L.","family":"St. Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patti L.","family":"Ephraim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aidan","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deidra C.","family":"Crews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J.","family":"Scialla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana C.","family":"Miskulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wieneke M.","family":"Michels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Zager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klemens B.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert W.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Ebony","family":"Boulware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-25-20210226","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.114.04334","article-title":"Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study","volume":"65","author":"Bansal","year":"2015","journal-title":"Hypertension"},{"key":"R2-25-20210226","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000206698","article-title":"Home blood pressure measurements for managing hypertension in hemodialysis patients","volume":"30","author":"Agarwal","year":"2009","journal-title":"Am J Nephrol"},{"key":"R3-25-20210226","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.ajkd.2014.03.015","article-title":"Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study","volume":"64","author":"Shafi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R4-25-20210226","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/sdi.12195","article-title":"Management of hypertension in in-center hemodialysis patients \u2013 an opinion-based update","volume":"27","author":"Shafi","year":"2014","journal-title":"Semin Dial"},{"key":"R5-25-20210226","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMra0902710","article-title":"Hemodialysis","volume":"363","author":"Himmelfarb","year":"2010","journal-title":"N Engl J Med"},{"key":"R6-25-20210226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1471-2369-14-249","article-title":"Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months","volume":"14","author":"St Peter","year":"2013","journal-title":"BMC Nephrol"},{"key":"R7-25-20210226","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2215\/CJN.03510414","article-title":"Utilization of acute care among patients with ESRD discharged home from skilled nursing facilities","volume":"10","author":"Hall","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R8-25-20210226","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2215\/CJN.00220115","article-title":"Overlooked care transitions: an opportunity to reduce acute care use in ESRD","volume":"10","author":"Erickson","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-25-20210226","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1681\/ASN.2014090860","article-title":"Measuring intradialytic hypotension to improve quality of care","volume":"26","author":"Daugirdas","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R10-25-20210226","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1681\/ASN.2013060667","article-title":"Predialysis systolic BP variability and outcomes in hemodialysis patients","volume":"25","author":"Shafi","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R11-25-20210226","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2215\/CJN.04470709","article-title":"Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function","volume":"4","author":"Burton","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-25-20210226","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1093\/ndt\/gft097","article-title":"Association of segmental wall motion abnormalities occurring during hemodialysis with post-dialysis fatigue","volume":"28","author":"Dubin","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R13-25-20210226","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1212\/01.wnl.0000225182.15532.40","article-title":"Cognitive impairment in hemodialysis patients is common","volume":"67","author":"Murray","year":"2006","journal-title":"Neurology"},{"key":"R14-25-20210226","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2215\/CJN.00030505","article-title":"Temporal relation among depression symptoms, cardiovascular disease events, and mortality in end-stage renal disease: contribution of reverse causality","volume":"1","author":"Boulware","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-25-20210226","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/hdi.12239","article-title":"Health numeracy: perspectives about using numbers in health management from African American patients receiving dialysis","volume":"19","author":"Wright Nunes","year":"2015","journal-title":"Hemodial Int"},{"key":"R16-25-20210226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ki.2012.425","article-title":"Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?","volume":"83","author":"Wheeler","year":"2013","journal-title":"Kidney Int"},{"key":"R17-25-20210226","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R18-25-20210226","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0735-1097(00)01158-X","article-title":"Dilated cardiomyopathy in dialysis patients \u2013 beneficial effects of carvedilol: a double-blind, placebo-controlled trial","volume":"37","author":"Cice","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R19-25-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R20-25-20210226","doi-asserted-by":"crossref","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"},{"key":"R21-25-20210226","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"R22-25-20210226","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"R23-25-20210226","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R24-25-20210226","doi-asserted-by":"crossref","first-page":"217","DOI":"10.31887\/DCNS.2011.13.2\/npatsopoulos","article-title":"A pragmatic view on pragmatic trials","volume":"13","author":"Patsopoulos","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"R25-25-20210226","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1745-6215-10-37","article-title":"Making trials matter: pragmatic and explanatory trials and the problem of applicability","volume":"10","author":"Treweek","year":"2009","journal-title":"Trials"},{"key":"R26-25-20210226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2369-13-167","article-title":"Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study","volume":"13","author":"Boulware","year":"2012","journal-title":"BMC Nephrol"},{"key":"R27-25-20210226","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","article-title":"A primer and comparative review of major US mortality databases","volume":"12","author":"Cowper","year":"2002","journal-title":"Ann Epidemiol"},{"key":"R29-25-20210226","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"R30-25-20210226","first-page":"488","article-title":"Using medicare data for comparative effectiveness research: opportunities and challenges","volume":"17","author":"Fung","year":"2011","journal-title":"Am J Manag Care"},{"key":"R31-25-20210226","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.2009.413","article-title":"An improved comorbidity index for outcome analyses among dialysis patients","volume":"77","author":"Liu","year":"2010","journal-title":"Kidney Int"},{"key":"R32-25-20210226","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.V113520","article-title":"Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD","volume":"11","author":"Longenecker","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R33-25-20210226","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"R34-25-20210226","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001648-200009000-00012","article-title":"Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men","volume":"11","author":"Hernan","year":"2000","journal-title":"Epidemiology"},{"key":"R35-25-20210226","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1198\/016214501753168154","article-title":"Marginal structural models to estimate the joint causal effect of nonrandomized treatments","volume":"96","author":"Hern\u00e1n","year":"2001","journal-title":"J Am Stat Assoc"},{"key":"R37-25-20210226","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R38-25-20210226","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R39-25-20210226","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"key":"R40-25-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MAJ.0b013e31827daee5","article-title":"Design of the blood pressure goals in dialysis pilot study","volume":"347","author":"Gul","year":"2014","journal-title":"Am J Med Sci"},{"key":"R41-25-20210226","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R42-25-20210226","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"R43-25-20210226","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3317\/jraas.2008.003","article-title":"Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial","volume":"9","author":"Schneider","year":"2008","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R44-25-20210226","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2215\/CJN.07831109","article-title":"Cardiovascular effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in hemodialysis: a meta-analysis","volume":"5","author":"Tai","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R45-25-20210226","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1536\/ihj.49.385","article-title":"Effect of angiotensin converting enzyme inhibitors and beta-blockers on left ventricular remodeling after coronary artery bypass graft surgery","volume":"49","author":"Maruyama","year":"2008","journal-title":"Int Heart J"},{"key":"R46-25-20210226","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200003303421301","article-title":"Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study","volume":"342","author":"Gress","year":"2000","journal-title":"N Engl J Med"},{"key":"R47-25-20210226","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.HYP.0000125727.92964.e2","article-title":"When does new onset diabetes resulting from antihypertensive therapy increase cardiovascular risk","volume":"43","author":"Bakris","year":"2004","journal-title":"Hypertension"},{"key":"R48-25-20210226","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2337\/dc06-0186","article-title":"Antihypertensive therapy and the risk of new-onset diabetes","volume":"29","author":"Sarafidis","year":"2006","journal-title":"Diabetes Care"},{"key":"R49-25-20210226","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dialysis Transplant"},{"key":"R50-25-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.ackd.2012.01.001","article-title":"Confounding and control of confounding in nonexperimental studies of medications in patients with CKD","volume":"19","author":"Bradbury","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"key":"R51-25-20210226","doi-asserted-by":"crossref","first-page":"f6409","DOI":"10.1136\/bmj.f6409","article-title":"Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research","volume":"347","author":"Freemantle","year":"2013","journal-title":"BMJ"},{"key":"R52-25-20210226","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2008.11.068","article-title":"Is the relationship between beta-blocker-induced heart rate lowering and cardiovascular outcomes the result of confounding by indication?","volume":"53","author":"Phillips","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R53-25-20210226","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jama.2010.1205","article-title":"Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction","volume":"304","author":"Psaty","year":"2010","journal-title":"JAMA"},{"key":"R54-25-20210226","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/ajkd.2002.33395","article-title":"A comparison of standardized versus \u201cusual\u201d blood pressure measurements in hemodialysis patients","volume":"39","author":"Rahman","year":"2002","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:27:34Z","timestamp":1750274854000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201702030-00025"}},"subtitle":["Evidence from a cohort study to inform hypertension treatment practices"],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005924","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]}}}